• DOI:10.1177/1933719112438061
Corpus ID: 2882899

The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis

@article{Chwalisz2012TheHP,
  title={The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis},
  author={K. Chwalisz and E. Surrey and F. Stanczyk},
  journal={Reproductive Sciences},
  year={2012},
  volume={19},
  pages={563 - 571}
}

K. Chwalisz, E. Surrey, F. Stanczyk

Published 2012

Medicine

Reproductive Sciences

Gonadotropin-releasing hormone agonists (GnRHa) are an effective treatment of endometriosis-associated pelvic pain. The use of hormonal add-back therapy can alleviate the hypoestrogenic symptoms associated with GnRHa therapy, while preserving therapeutic efficacy. Norethindrone acetate (NETA) is a unique progestin that has both estrogenic and androgenic properties and is effective as an add-back regimen without estrogen supplementation. Through its estrogenic activity, NETA exerts beneficial… CONTINUE READING

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed